(Q57811178)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30347635%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

title

New Perspectives in Iron Chelation Therapy for the Treatment of Neurodegenerative Diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30347635%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30347635%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

author name string

Pedro Chana-Cuevas

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30347635%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

language of work or name

English

0 references

publication date

19 October 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30347635%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30347635%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30347635%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30347635%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

29 April 2020

copyright license

start time

19 October 2018

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Hallervorden-Spatz syndrome

1 reference

12 December 2020

Hallervorden-Spatz Syndrome and Brain Iron Metabolism

1 reference

12 December 2020

1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles

1 reference

12 December 2020

Latent iron deficiency alters gamma-aminobutyric acid and glutamate metabolism in rat brain

1 reference

12 December 2020

Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?

1 reference

12 December 2020

Magnetic resonance imaging in pathologically proven Hallervorden-Spatz disease

1 reference

12 December 2020

Modulation of brain acetylcholine levels with cholinesterase inhibitors as a treatment of Alzheimer disease

1 reference

12 December 2020

Impaired phenylalanine-tyrosine conversion in patients with iron-deficiency anemia studied by a L-(2H5)phenylalanine-loading test.

1 reference

12 December 2020

Depletion of excessive liver iron stores with desferrioxamine

1 reference

12 December 2020

Iron status and anemia in the elderly: new findings and a review of previous studies

1 reference

12 December 2020

Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome

1 reference

12 December 2020

Zinc concentration in patients with iron overload receiving oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one or desferrioxamine

1 reference

12 December 2020

Iron accumulation in Alzheimer disease is a source of redox-generated free radicals

1 reference

12 December 2020

Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter.

1 reference

12 December 2020

A risk-benefit assessment of iron-chelation therapy

1 reference

12 December 2020

A novel splicing mutation in the ceruloplasmin gene responsible for hereditary ceruloplasmin deficiency with hemosiderosis.

1 reference

12 December 2020

Iron-sulfur clusters/semiquinones in complex I.

1 reference

12 December 2020

Metabolic activation of dopamine o-quinones to o-semiquinones by NADPH cytochrome P450 reductase may play an important role in oxidative stress and apoptotic effects

1 reference

12 December 2020

Effects of iron deficiency on iron distribution and gamma-aminobutyric acid (GABA) metabolism in young rat brain tissues

1 reference

12 December 2020

Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter.

1 reference

12 December 2020

Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase

1 reference

12 December 2020

Increased basal ganglia iron levels in Huntington disease

1 reference

12 December 2020

Scavenging of hydrogen peroxide and inhibition of ultraviolet light-induced oxidative DNA damage by aqueous extracts from green and black teas.

1 reference

12 December 2020

Neuroaxonal dystrophy with dystonia and pallidal involvement.

1 reference

12 December 2020

Dopamine transporters and neuronal injury

1 reference

12 December 2020

In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging

1 reference

12 December 2020

Juvenile-onset generalized neuroaxonal dystrophy (Hallervorden-Spatz disease) with diffuse neurofibrillary and lewy body pathology

1 reference

12 December 2020

Friedreich's ataxia and iron metabolism

1 reference

12 December 2020

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

1 reference

12 December 2020

Development of potential iron chelators for the treatment of Friedreich's ataxia: ligands that mobilize mitochondrial iron

1 reference

12 December 2020

Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease

1 reference

12 December 2020

Iron in the Hallervorden-Spatz syndrome

1 reference

12 December 2020

Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration

1 reference

12 December 2020

Friedreich's ataxia: clinical aspects and pathogenesis

1 reference

12 December 2020

The copper-iron connection: hereditary aceruloplasminemia

1 reference

12 December 2020

Direct scavenging of nitric oxide and superoxide by green tea.

1 reference

12 December 2020

Effects of green tea polyphenols on dopamine uptake and on MPP+ -induced dopamine neuron injury

1 reference

12 December 2020

Friedreich's ataxia: iron chelators that target the mitochondrion as a therapeutic strategy?

1 reference

12 December 2020

Adventiously-bound redox active iron and copper are at the center of oxidative damage in Alzheimer disease

1 reference

12 December 2020

Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone

1 reference

12 December 2020

Differential diagnosis of Parkinson's disease and atypical parkinsonian disorders by magnetic resonance imaging

1 reference

12 December 2020

alpha-synuclein aggregation: a link between mitochondrial defects and Parkinson's disease?

1 reference

12 December 2020

The effect of age on the non-haemin iron in the human brain.

1 reference

12 December 2020

Antioxidant Activity of Tea Polyphenols In Vivo: Evidence from Animal Studies

1 reference

12 December 2020

Role of Protein Aggregation in Mitochondrial Dysfunction and Neurodegeneration in Alzheimer's and Parkinson's Diseases

1 reference

12 December 2020

Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial

1 reference

12 December 2020

Green tea polyphenol (-)-epigallocatechin-3-gallate protects rat PC12 cells from apoptosis induced by serum withdrawal independent of P13-Akt pathway

1 reference

12 December 2020

On the neurotoxicity mechanism of leukoaminochrome o-semiquinone radical derived from dopamine oxidation: mitochondria damage, necrosis, and hydroxyl radical formation

1 reference

12 December 2020

Iron, brain ageing and neurodegenerative disorders

1 reference

12 December 2020

Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer's, Parkinson's, and other neurodegenerative diseases.

1 reference

12 December 2020

Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate

1 reference

12 December 2020

Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells

1 reference

12 December 2020

Dopamine-derived dopaminochrome promotes H(2)O(2) release at mitochondrial complex I: stimulation by rotenone, control by Ca(2+), and relevance to Parkinson disease

1 reference

12 December 2020

Green tea polyphenol epigallocatechin-3-gallate differentially modulates oxidative stress in PC12 cell compartments

1 reference

12 December 2020

Neuroprotection of MPTP-induced toxicity in zebrafish dopaminergic neurons

1 reference

12 December 2020

Glucose transport to the brain: a systems model

1 reference

12 December 2020

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia

1 reference

12 December 2020

Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system

1 reference

12 December 2020

Epigallocatechin gallate protects dopaminergic neurons against 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by inhibiting microglial cell activation.

1 reference

12 December 2020

(-)-Epigallocatechin gallate regulates dopamine transporter internalization via protein kinase C-dependent pathway.

1 reference

12 December 2020

Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase

1 reference

12 December 2020

Fatal agranulocytosis after deferiprone therapy in a child with Diamond-Blackfan anemia.

1 reference

12 December 2020

Selective iron chelation in Friedreich ataxia: biologic and clinical implications.

1 reference

12 December 2020

Combating Alzheimer's disease with multifunctional molecules designed for metal passivation.

1 reference

12 December 2020

Epigallocatechin gallate dose-dependently induces apoptosis or necrosis in human MCF-7 cells

1 reference

12 December 2020

Iron dyshomeostasis in Parkinson's disease

1 reference

12 December 2020

Synthesis, characterization, and metal coordinating ability of multifunctional carbohydrate-containing compounds for Alzheimer's therapy.

1 reference

12 December 2020

Iron dysregulation in Alzheimer's disease: multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agents

1 reference

12 December 2020

Non-transferrin-bound iron reaches mitochondria by a chelator-inaccessible mechanism: biological and clinical implications.

1 reference

12 December 2020

Induction of apoptosis by epigallocatechin-3-gallate in human lymphoblastoid B cells

1 reference

12 December 2020

Past, present, and future technologies for oral delivery of therapeutic proteins

1 reference

12 December 2020

Flavonoids-induced accumulation of hypoxia-inducible factor (HIF)-1alpha/2alpha is mediated through chelation of iron

1 reference

12 December 2020

Redistribution of accumulated cell iron: a modality of chelation with therapeutic implications

1 reference

12 December 2020

Multi-target-directed drug design strategy: from a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against Alzheimer's disease.

1 reference

12 December 2020

T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation

1 reference

12 December 2020

Deferiprone in the treatment of transfusion-dependent thalassemia: a review and perspective

1 reference

12 December 2020

Intranasal mucoadhesive microemulsion of tacrine to improve brain targeting

1 reference

12 December 2020

Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial

1 reference

12 December 2020

Epigallocatechin-3-gallate induced primary cultures of rat hippocampal neurons death linked to calcium overload and oxidative stress

1 reference

12 December 2020

Molecular mechanisms of copper homeostasis

1 reference

12 December 2020

Prooxidative effects of green tea polyphenol (-)-epigallocatechin-3-gallate on the HIT-T15 pancreatic beta cell line

1 reference

12 December 2020

Up-regulation of hypoxia-inducible factor (HIF)-1α and HIF-target genes in cortical neurons by the novel multifunctional iron chelator anti-Alzheimer drug, M30.

1 reference

12 December 2020

Safety issues of iron chelation therapy in patients with normal range iron stores including thalassaemia, neurodegenerative, renal and infectious diseases

1 reference

12 December 2020

Discovery of 4-(4-(2-((5-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)(propyl)amino)ethyl)piperazin-1-yl)quinolin-8-ol and its analogues as highly potent dopamine D2/D3 agonists and as iron chelator: in vivo activity indicates potential application in

1 reference

12 December 2020

PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses

1 reference

12 December 2020

ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation

1 reference

12 December 2020

Tacrine derivatives and Alzheimer's disease.

1 reference

12 December 2020

Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties

1 reference

12 December 2020

Brain iron metabolism and its perturbation in neurological diseases.

1 reference

12 December 2020

Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA).

1 reference

12 December 2020

Combined therapy with idebenone and deferiprone in patients with Friedreich's ataxia.

1 reference

12 December 2020

Iron-overload cardiomyopathy: pathophysiology, diagnosis, and treatment

1 reference

12 December 2020

Mitochondrial Dysfunction: The Road to Alpha-Synuclein Oligomerization in PD.

1 reference

12 December 2020

Modulation of Ca²⁺ signals by epigallocatechin-3-gallate(EGCG) in cultured rat hippocampal neurons

1 reference

12 December 2020

Anti-inflammatory and anti-oxidative effects of the green tea polyphenol epigallocatechin gallate in human corneal epithelial cells

1 reference

12 December 2020

1 reference

12 December 2020

Novel molecular targets of the neuroprotective/neurorescue multimodal iron chelating drug M30 in the mouse brain.

1 reference

12 December 2020

Effect of mitochondrial complex I inhibition on Fe-S cluster protein activity

1 reference

12 December 2020

1 reference

12 December 2020

A pilot trial of deferiprone for neurodegeneration with brain iron accumulation

1 reference

12 December 2020

Design, synthesis, and biological evaluation of curcumin analogues as multifunctional agents for the treatment of Alzheimer's disease

1 reference

12 December 2020

Early-onset neurodegeneration with brain iron accumulation due to PANK2 mutation.

1 reference

12 December 2020

Involvement of globus pallidus and midbrain nuclei in pantothenate kinase-associated neurodegeneration: measurement of T2 and T2* time

1 reference

12 December 2020

Management of transfusional iron overload - differential properties and efficacy of iron chelating agents

1 reference

12 December 2020

Iron toxicity in neurodegeneration.

1 reference

12 December 2020

Iron mobilization using chelation and phlebotomy

1 reference

12 December 2020

An update on iron chelation therapy

1 reference

12 December 2020

Magnetic resonance imaging in pantothenate kinase-2-associated neurodegeneration

1 reference

12 December 2020

Multi-target, neuroprotective and neurorestorative M30 improves cognitive impairment and reduces Alzheimer's-like neuropathology and age-related alterations in mice.

1 reference

12 December 2020

O-Hydroxyl- or o-amino benzylamine-tacrine hybrids: multifunctional biometals chelators, antioxidants, and inhibitors of cholinesterase activity and amyloid-β aggregation.

1 reference

12 December 2020

Multitarget-directed benzylideneindanone derivatives: anti-β-amyloid (Aβ) aggregation, antioxidant, metal chelation, and monoamine oxidase B (MAO-B) inhibition properties against Alzheimer's disease.

1 reference

12 December 2020

Higher transport and metabolism of glucose in astrocytes compared with neurons: a multiphoton study of hippocampal and cerebellar tissue slices

1 reference

12 December 2020

New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPAN.

1 reference

12 December 2020

α-Synuclein and mitochondrial dysfunction in Parkinson's disease

1 reference

12 December 2020

Mitochondrial membrane protein associated neurodegenration: a novel variant of neurodegeneration with brain iron accumulation

1 reference

12 December 2020

Multifunctional iron-chelators with protective roles against neurodegenerative diseases.

1 reference

12 December 2020

Triple therapy with deferiprone, idebenone and riboflavin in Friedreich's ataxia - open-label trial

1 reference

12 December 2020

Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and parkinsonian variant of multiple system atrophy

1 reference

12 December 2020

Deferiprone for the treatment of Friedreich's ataxia.

1 reference

12 December 2020

Oral deferiprone for iron chelation in people with thalassaemia

1 reference

12 December 2020

Pantothenate kinase-associated neurodegeneration (PKAN) and PLA2G6-associated neurodegeneration (PLAN): review of two major neurodegeneration with brain iron accumulation (NBIA) phenotypes

1 reference

12 December 2020

Mitochondrial membrane protein-associated neurodegeneration (MPAN).

1 reference

12 December 2020

BPAN: the only X-linked dominant NBIA disorder

1 reference

12 December 2020

Targeting chelatable iron as a therapeutic modality in Parkinson's disease

1 reference

12 December 2020

Promises of novel multi-target neuroprotective and neurorestorative drugs for Parkinson's disease

1 reference

12 December 2020

Exome sequence reveals mutations in CoA synthase as a cause of neurodegeneration with brain iron accumulation

1 reference

12 December 2020

Beta-propeller protein-associated neurodegeneration (BPAN), a rare form of NBIA: novel mutations and neuropsychiatric phenotype in three adult patients.

1 reference

12 December 2020

Cardiac involvement in hemochromatosis

1 reference

12 December 2020

The interplay between iron accumulation, mitochondrial dysfunction, and inflammation during the execution step of neurodegenerative disorders

1 reference

12 December 2020

Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): results from a four years follow-up.

1 reference

12 December 2020

The molecular biology of human iron metabolism

1 reference

12 December 2020

Update on neurodegeneration with brain iron accumulation

1 reference

12 December 2020

Deferiprone in Friedreich ataxia: a 6-month randomized controlled trial.

1 reference

12 December 2020

The role of iron in brain ageing and neurodegenerative disorders.

1 reference

12 December 2020

Safety, tolerability, and efficacy of PBT2 in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

Tea polyphenols alleviate motor impairments, dopaminergic neuronal injury, and cerebral α-synuclein aggregation in MPTP-intoxicated parkinsonian monkeys.

1 reference

12 December 2020

Neuroprotective and neurorestorative activities of a novel iron chelator-brain selective monoamine oxidase-A/monoamine oxidase-B inhibitor in animal models of Parkinson's disease and aging.

1 reference

12 December 2020

Neurodegeneration with brain iron accumulation: an overview

1 reference

12 December 2020

Mitochondrial iron homeostasis and its dysfunctions in neurodegenerative disorders

1 reference

12 December 2020

Mitochondria: A crossroads for lipid metabolism defect in neurodegeneration with brain iron accumulation diseases

1 reference

12 December 2020

Neurodegenerative diseases and therapeutic strategies using iron chelators

1 reference

12 December 2020

Neuroferritinopathy: From ferritin structure modification to pathogenetic mechanism

1 reference

12 December 2020

Synthesis and evaluation of selegiline derivatives as monoamine oxidase inhibitor, antioxidant and metal chelator against Alzheimer's disease

1 reference

12 December 2020

Ceruloplasmin activity and iron chelation treatment of patients with Parkinson's disease

1 reference

12 December 2020

Neurodegeneration with Brain Iron Accumulation: Genetic Diversity and Pathophysiological Mechanisms

1 reference

12 December 2020

Iron chelation therapy in transfusion-dependent thalassemia patients: current strategies and future directions

1 reference

12 December 2020

Aggregated α-synuclein and complex I deficiency: exploration of their relationship in differentiated neurons

1 reference

12 December 2020

A Speciation Study on the Perturbing Effects of Iron Chelators on the Homeostasis of Essential Metal Ions

1 reference

12 December 2020

Novel 1-Phenyl-3-hydroxy-4-pyridinone Derivatives as Multifunctional Agents for the Therapy of Alzheimer's Disease

1 reference

12 December 2020

Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics

1 reference

12 December 2020

Optimizing the diagnosis and the treatment of iron overload diseases

1 reference

12 December 2020

Ferroptosis: Death by Lipid Peroxidation

1 reference

12 December 2020

Mutational analysis of COASY in an Italian patient with NBIA

1 reference

12 December 2020

Clinical Experience With Deferiprone Treatment for Friedreich Ataxia.

1 reference

12 December 2020

Iron chelation in the treatment of neurodegenerative diseases

1 reference

12 December 2020

Frataxin and the molecular mechanism of mitochondrial iron-loading in Friedreich's ataxia

1 reference

12 December 2020

Beneficial Effects of Multitarget Iron Chelator on Central Nervous System and Gastrocnemius Muscle in SOD1(G93A) Transgenic ALS Mice.

1 reference

12 December 2020

Current recommendations for chelation for transfusion-dependent thalassemia

1 reference

12 December 2020

Targeting copper(II)-induced oxidative stress and the acetylcholinesterase system in Alzheimer's disease using multifunctional tacrine-coumarin hybrid molecules.

1 reference

12 December 2020

Parkinson's Disease: The Mitochondria-Iron Link

1 reference

12 December 2020

Neurodegeneration with brain iron accumulation

1 reference

12 December 2020

A diagnostic approach for neurodegeneration with brain iron accumulation: clinical features, genetics and brain imaging.

1 reference

12 December 2020

Low-Intensity Ultrasound Decreases α-Synuclein Aggregation via Attenuation of Mitochondrial Reactive Oxygen Species in MPP(+)-Treated PC12 Cells

1 reference

12 December 2020

Neuroprotective Effect of a New 7,8-Dihydroxycoumarin-Based Fe2+/Cu2+ Chelator in Cell and Animal Models of Parkinson's Disease.

1 reference

12 December 2020

A Novel Iron Chelator-Radical Scavenger Ameliorates Motor Dysfunction and Improves Life Span and Mitochondrial Biogenesis in SOD1G93A ALS Mice.

1 reference

12 December 2020

Safety profiles of iron chelators in young patients with haemoglobinopathies

1 reference

12 December 2020

Iron-Sulfur Clusters in Mitochondrial Metabolism: Multifaceted Roles of a Simple Cofactor.

1 reference

12 December 2020

Iron mediated toxicity and programmed cell death: A review and a re-examination of existing paradigms

1 reference

12 December 2020

Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility.

1 reference

12 December 2020

A Novel Iron(II) Preferring Dopamine Agonist Chelator as Potential Symptomatic and Neuroprotective Therapeutic Agent for Parkinson's Disease.

1 reference

12 December 2020

Involvement of PKCα and ERK1/2 signaling pathways in EGCG's protection against stress-induced neural injuries in Wistar rats.

1 reference

12 December 2020

Mitochondrial membrane protein-associated neurodegeneration.

1 reference

12 December 2020

Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease

1 reference

12 December 2020

Deferiprone for the treatment of transfusional iron overload in thalassemia

1 reference

12 December 2020

Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson's disease.

1 reference

12 December 2020

Diagnosis of CoPAN by whole exome sequencing: Waking up a sleeping tiger's eye.

1 reference

12 December 2020

Cell death induced by mitochondrial complex I inhibition is mediated by Iron Regulatory Protein 1.

1 reference

12 December 2020

Biomonitorization of iron accumulation in the substantia nigra from Lewy body disease patients

1 reference

12 December 2020

A novel iron (II) preferring dopamine agonist chelator D-607 significantly suppresses α-syn- and MPTP-induced toxicities in vivo.

1 reference

12 December 2020

The novel multitarget iron chelating and propargylamine drug M30 affects APP regulation and processing activities in Alzheimer's disease models

1 reference

12 December 2020

Epigallocatechin-3-Gallate Protects against Homocysteine-Induced Brain Damage in Rats

1 reference

12 December 2020

Iron in neurodegenerative disorders: being in the wrong place at the wrong time?

1 reference

12 December 2020

Deferasirox for managing iron overload in people with thalassaemia

1 reference

12 December 2020

Epigallocatechin Gallate Has a Neurorescue Effect in a Mouse Model of Parkinson Disease.

1 reference

12 December 2020

Patient Affected by Beta-Propeller Protein-Associated Neurodegeneration: A Therapeutic Attempt with Iron Chelation Therapy

1 reference

12 December 2020

New targeted therapies and diagnostic methods for iron overload diseases.

1 reference

12 December 2020

Brain regional iron contents in progressive supranuclear palsy.

1 reference

12 December 2020

Neurodegeneration with brain iron accumulation

1 reference

12 December 2020

Postmortem MRI and histology demonstrate differential iron accumulation and cortical myelin organization in early- and late-onset Alzheimer's disease.

1 reference

12 December 2020

Development of an iron-selective antioxidant probe with protective effects on neuronal function.

1 reference

12 December 2020

Mitochondria and α-Synuclein: Friends or Foes in the Pathogenesis of Parkinson's Disease?

1 reference

12 December 2020

Neurodegeneration with brain iron accumulation

1 reference

12 December 2020

Iron as a therapeutic target for Parkinson's disease

1 reference

12 December 2020

Iron Chelation Therapy as a Modality of Management.

1 reference

12 December 2020

Novel Tacrine-Hydroxyphenylbenzimidazole hybrids as potential multitarget drug candidates for Alzheimer's disease.

1 reference

12 December 2020

Neuroprotective Effects and Mechanisms of Tea Bioactive Components in Neurodegenerative Diseases.

1 reference

12 December 2020

Iron overload cardiomyopathy: from diagnosis to management

1 reference

12 December 2020

Unraveling the Burden of Iron in Neurodegeneration: Intersections with Amyloid Beta Peptide Pathology.

1 reference

12 December 2020

A pilot trial of deferiprone in pantothenate kinase-associated neurodegeneration patients.

1 reference

12 December 2020

The effect of iron chelation therapy on overall survival in sickle cell disease and β-thalassemia: A systematic review.

1 reference

12 December 2020

Iron and Alzheimer's Disease: An Update on Emerging Mechanisms

1 reference

12 December 2020

Oxidative stress and neurodegeneration: the involvement of iron

1 reference

12 December 2020

Identifiers

DOI

10.3390/PH11040109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30347635%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30347635%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

1 reference